Description: Avecho Biotechnology Limited, formerly Phosphagenics Limited, is an Australia-based research-based biotechnology company. The principal activities of the Company are the development, production, sale and licensing of products incorporating its platform technology Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care, and animal health and nutrition industries. The Company's segments include Production and Personal Care, and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers delivery of drugs through gels, injectables and patches. The Human Health segment focuses on development of patches, including TPM/Oxymorphone and TPM/Oxycodone. The Company has various development programs under its animal health and nutrition. The Company has completed multiple studies assessing TPM as a feed additive in pigs and poultry.
Home Page: avecho.com.au
AVE Technical Analysis
C/O Ultimus Fund Solutions, LLC
,
Phone:
888-726-9331
Officers
| Name | Title |
|---|---|
| Dr. Paul Gavin BSc (Hons), Ph.D. | Chief Exec. Officer |
| Dr. Roksan Libinaki Ph.D. | Chief Operating Officer |
| Ms. Melanie Jaye Leydin B.Bus, C.A., CA | Company Sec. & CFO |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.7903 |
| Price-to-Sales TTM: | 14.292 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |